Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis.

Area of Science:

• * Pharmacology
• * Oncology
• * Natural Product Chemistry

Background:

• * Cancer remains a leading global cause of death despite extensive research and treatments.
• * Current cancer therapies (chemotherapy, etc.) have severe adverse effects.
• * Natural products, particularly ginsenosides, offer a promising source for novel anti-cancer drug development.

Purpose of the Study:

• * To review the anti-cancer therapeutic potential of various ginsenoside compounds.
• * To analyze their mechanisms of action against cancer.
• * To consider ginsenosides for new cancer treatment strategies.

Main Methods:

• * Comprehensive literature review of studies on ginsenosides and cancer.
• * Analysis of research on ginsenosides targeting cancer signaling pathways.
• * Examination of molecular mechanisms including autophagy, apoptosis, and cell cycle regulation.

Main Results:

• * Ginsenosides (e.g., Rb1, Rg3, Rh2) target multiple cancer-related pathways.
• * Mechanisms include induction of autophagy, apoptosis, cell cycle arrest, and modulation of key molecules (p53, NF-Kb, Bcl-2).
• * Ginsenosides demonstrate potential in neutralizing reactive oxygen species (ROS) and inhibiting inflammatory pathways.

Conclusions:

• * Ginsenosides exhibit broad-spectrum anti-cancer properties.
• * Their ability to target diverse pathways makes them valuable candidates for novel cancer therapies.
• * Further research into ginsenosides could lead to more effective and safer cancer treatment strategies.